$CYTK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTOKINETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CYTOKINETICS INC. Get notifications about new insider transactions in CYTOKINETICS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 17 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 12.48 | 200 | 2,495 | 22,417 | 22.6 K to 22.4 K (-0.88 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 12.45 | 2,300 | 28,635 | 22,617 | 24.9 K to 22.6 K (-9.23 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 12.43 | 800 | 9,940 | 24,917 | 25.7 K to 24.9 K (-3.11 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 12.40 | 3,200 | 39,680 | 25,717 | 28.9 K to 25.7 K (-11.07 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Buy | M | 6.37 | 5,411 | 34,468 | 28,917 | 23.5 K to 28.9 K (+23.02 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 12.38 | 500 | 6,188 | 23,506 | 24 K to 23.5 K (-2.08 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Buy | M | 6.67 | 2,736 | 18,249 | 24,006 | 21.3 K to 24 K (+12.86 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 12.35 | 300 | 3,705 | 21,270 | 21.6 K to 21.3 K (-1.39 %) |
Aug 10 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Buy | M | 6.67 | 1,391 | 9,278 | 21,570 | 20.2 K to 21.6 K (+6.89 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.20 | 177 | 2,513 | 79,885 | 80.1 K to 79.9 K (-0.22 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.90 | 405 | 5,630 | 80,062 | 80.5 K to 80.1 K (-0.50 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.88 | 500 | 6,938 | 80,467 | 81 K to 80.5 K (-0.62 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.85 | 695 | 9,626 | 80,967 | 81.7 K to 81 K (-0.85 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.83 | 100 | 1,383 | 81,662 | 81.8 K to 81.7 K (-0.12 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.80 | 1,123 | 15,497 | 81,762 | 82.9 K to 81.8 K (-1.35 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.75 | 300 | 4,125 | 82,885 | 83.2 K to 82.9 K (-0.36 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.70 | 900 | 12,330 | 83,185 | 84.1 K to 83.2 K (-1.07 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.68 | 100 | 1,368 | 84,085 | 84.2 K to 84.1 K (-0.12 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.65 | 500 | 6,825 | 84,185 | 84.7 K to 84.2 K (-0.59 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.60 | 100 | 1,360 | 84,685 | 84.8 K to 84.7 K (-0.12 %) |
Aug 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.55 | 100 | 1,355 | 84,785 | 84.9 K to 84.8 K (-0.12 %) |
Jul 05 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 12.20 | 309 | 3,770 | 84,885 | 85.2 K to 84.9 K (-0.36 %) |
Jul 05 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 12.18 | 100 | 1,218 | 85,194 | 85.3 K to 85.2 K (-0.12 %) |
Jul 05 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 12.15 | 3,091 | 37,556 | 85,294 | 88.4 K to 85.3 K (-3.50 %) |
Jul 05 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 12.10 | 1,500 | 18,150 | 88,385 | 89.9 K to 88.4 K (-1.67 %) |
Jun 30 2017 | CYTK | CYTOKINETICS INC | Jaw Ching | SVP Finance & CFO | Option Exercise | A | 12.10 | 41,944 | 507,522 | 41,944 | |
Jun 30 2017 | CYTK | CYTOKINETICS INC | Jaw Ching | SVP Finance & CFO | Option Exercise | A | 12.10 | 33,056 | 399,978 | 33,056 | |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.85 | 100 | 1,385 | 89,885 | 90 K to 89.9 K (-0.11 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.80 | 400 | 5,520 | 89,985 | 90.4 K to 90 K (-0.44 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.75 | 800 | 11,000 | 90,385 | 91.2 K to 90.4 K (-0.88 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.70 | 200 | 2,740 | 91,185 | 91.4 K to 91.2 K (-0.22 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.65 | 700 | 9,555 | 91,385 | 92.1 K to 91.4 K (-0.76 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.60 | 800 | 10,880 | 92,085 | 92.9 K to 92.1 K (-0.86 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.55 | 932 | 12,629 | 92,885 | 93.8 K to 92.9 K (-0.99 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.50 | 500 | 6,750 | 93,817 | 94.3 K to 93.8 K (-0.53 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.45 | 468 | 6,295 | 94,317 | 94.8 K to 94.3 K (-0.49 %) |
Jun 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 13.40 | 100 | 1,340 | 94,785 | 94.9 K to 94.8 K (-0.11 %) |
May 22 2017 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
May 22 2017 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
May 22 2017 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
May 22 2017 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
May 22 2017 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
May 22 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
May 22 2017 | CYTK | CYTOKINETICS INC | COSTA SANTO J | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Option Exercise | A | 10.60 | 8,580 | 90,948 | 8,580 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Option Exercise | A | 10.60 | 6,420 | 68,052 | 6,420 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Grant | A | 0.00 | 15,000 | 15 | 47,255 | 32.3 K to 47.3 K (+46.50 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Payment of Exercise | F | 10.60 | 4,984 | 52,830 | 32,255 | 37.2 K to 32.3 K (-13.38 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Grant | A | 0.00 | 12,500 | 13 | 37,239 | 24.7 K to 37.2 K (+50.53 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Payment of Exercise | F | 10.60 | 7,317 | 77,560 | 40,323 | 47.6 K to 40.3 K (-15.36 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Grant | A | 0.00 | 18,750 | 19 | 47,640 | 28.9 K to 47.6 K (+64.90 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Schnieders Elisabeth | Sr. VP, Business De ... | Option Exercise | A | 10.60 | 11,177 | 118,476 | 11,177 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Schnieders Elisabeth | Sr. VP, Business De ... | Option Exercise | A | 10.60 | 8,823 | 93,524 | 8,823 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Schnieders Elisabeth | Sr. VP, Business De ... | Grant | A | 0.00 | 20,000 | 20 | 43,919 | 23.9 K to 43.9 K (+83.62 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Schnieders Elisabeth | Sr. VP, Business De ... | Payment of Exercise | F | 10.60 | 5,066 | 53,700 | 23,919 | 29 K to 23.9 K (-17.48 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Schnieders Elisabeth | Sr. VP, Business De ... | Grant | A | 0.00 | 12,500 | 13 | 28,985 | 16.5 K to 29 K (+75.83 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 10.60 | 13,537 | 143,492 | 13,537 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 10.60 | 6,463 | 68,508 | 6,463 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Grant | A | 0.00 | 20,000 | 20 | 45,194 | 25.2 K to 45.2 K (+79.38 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Payment of Exercise | F | 10.60 | 5,986 | 63,452 | 25,194 | 31.2 K to 25.2 K (-19.20 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Grant | A | 0.00 | 15,000 | 15 | 31,180 | 16.2 K to 31.2 K (+92.71 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Option Exercise | A | 10.60 | 8,575 | 90,895 | 8,575 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Option Exercise | A | 10.60 | 6,425 | 68,105 | 6,425 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Grant | A | 0.00 | 15,000 | 15 | 18,581 | 3.6 K to 18.6 K (+418.88 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Option Exercise | A | 10.60 | 41,105 | 435,713 | 41,105 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Option Exercise | A | 10.60 | 8,895 | 94,287 | 8,895 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Grant | A | 0.00 | 30,000 | 30 | 45,404 | 15.4 K to 45.4 K (+194.75 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Payment of Exercise | F | 10.60 | 9,631 | 102,089 | 15,404 | 25 K to 15.4 K (-38.47 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Grant | A | 0.00 | 25,000 | 25 | 25,035 | 35 to 25 K (+71,428.57 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Option Exercise | A | 10.60 | 14,166 | 150,160 | 14,166 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Option Exercise | A | 10.60 | 5,834 | 61,840 | 5,834 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Grant | A | 0.00 | 20,000 | 20 | 48,018 | 28 K to 48 K (+71.38 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Payment of Exercise | F | 10.60 | 6,008 | 63,685 | 28,018 | 34 K to 28 K (-17.66 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Grant | A | 0.00 | 15,000 | 15 | 34,026 | 19 K to 34 K (+78.84 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Option Exercise | A | 10.60 | 13,850 | 146,810 | 13,850 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Option Exercise | A | 10.60 | 6,150 | 65,190 | 6,150 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Grant | A | 0.00 | 20,000 | 20 | 29,004 | 9 K to 29 K (+222.12 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Payment of Exercise | F | 10.60 | 5,996 | 63,558 | 9,004 | 15 K to 9 K (-39.97 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Grant | A | 0.00 | 15,000 | 15 | 15,000 | 0 to 15 K |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | A | 10.60 | 194,235 | 2,058,891 | 194,235 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | A | 10.60 | 10,765 | 114,109 | 10,765 | |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Payment of Exercise | F | 10.60 | 17,007 | 180,274 | 93,768 | 110.8 K to 93.8 K (-15.35 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Grant | A | 0.00 | 45,000 | 45 | 110,775 | 65.8 K to 110.8 K (+68.42 %) |
Mar 02 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Grant | A | 0.00 | 60,000 | 60 | 65,775 | 5.8 K to 65.8 K (+1,038.96 %) |
Jan 04 2017 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 12.40 | 4,032 | 49,997 | 4,032 | |
Jan 04 2017 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 12.40 | 4,032 | 49,997 | 4,032 | |
Jan 04 2017 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Director | Option Exercise | A | 12.40 | 4,032 | 49,997 | 4,032 | |
Jan 04 2017 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Option Exercise | A | 12.40 | 8,064 | 99,994 | 8,064 | |
Jan 04 2017 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 12.40 | 8,064 | 99,994 | 8,064 | |
Dec 30 2016 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Sell | S | 12.52 | 1,326 | 16,600 | 35 | 1.4 K to 35 (-97.43 %) |
Dec 30 2016 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Sell | S | 12.32 | 1,800 | 22,182 | 1,361 | 3.2 K to 1.4 K (-56.94 %) |
Dec 30 2016 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Sell | S | 12.31 | 200 | 2,461 | 3,161 | 3.4 K to 3.2 K (-5.95 %) |
Dec 30 2016 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Sell | S | 12.31 | 2,307 | 28,399 | 3,361 | 5.7 K to 3.4 K (-40.70 %) |
Jul 05 2016 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Option Exercise | A | 9.66 | 5,175 | 49,991 | 5,175 | |
May 20 2016 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Option Exercise | A | 7.61 | 35,000 | 266,350 | 35,000 | |
May 20 2016 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
May 20 2016 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
May 20 2016 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
May 20 2016 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
May 20 2016 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
May 20 2016 | CYTK | CYTOKINETICS INC | COSTA SANTO J | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Option Exercise | A | 6.67 | 39,359 | 262,525 | 39,359 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Cragg David | SVP Human Resources | Option Exercise | A | 6.67 | 15,641 | 104,325 | 15,641 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 40.86 | 193 | 7,886 | 193 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 20.22 | 1,033 | 20,887 | 1,033 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 18.48 | 721 | 13,324 | 721 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 11.10 | 694 | 7,703 | 1,389 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 11.10 | 695 | 7,715 | 695 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 9.65 | 11,552 | 111,477 | 11,552 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 9.42 | 617 | 5,812 | 617 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 7.96 | 18,956 | 150,890 | 18,956 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 6.67 | 31,183 | 207,991 | 31,183 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 6.30 | 1,079 | 6,798 | 1,079 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 6.00 | 3,795 | 22,770 | 3,795 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 42.24 | 5,000 | 211,200 | 5,000 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 40.86 | 3,106 | 126,911 | 3,106 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 20.22 | 2,101 | 42,482 | 2,101 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 18.48 | 4,278 | 79,057 | 7,611 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 18.48 | 3,333 | 61,594 | 3,333 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 11.10 | 2,639 | 29,293 | 5,277 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 11.10 | 2,638 | 29,282 | 2,638 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 9.65 | 18,448 | 178,023 | 18,448 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 9.42 | 11,883 | 111,938 | 11,883 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 7.96 | 11,044 | 87,910 | 11,044 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 6.67 | 18,817 | 125,509 | 18,817 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 6.30 | 13,920 | 87,696 | 13,920 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | A | 6.00 | 21,204 | 127,224 | 21,204 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Option Exercise | A | 6.67 | 33,084 | 220,670 | 33,084 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | CHARPENTIER BONNIE | SVP Regulatory & Co ... | Option Exercise | A | 6.67 | 16,916 | 112,830 | 16,916 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Option Exercise | A | 6.67 | 21,575 | 143,905 | 21,575 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP & CMO | Option Exercise | A | 6.67 | 18,425 | 122,895 | 18,425 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Option Exercise | A | 6.67 | 85,814 | 572,379 | 85,814 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Option Exercise | A | 6.67 | 14,186 | 94,621 | 14,186 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | A | 6.67 | 74,987 | 500,163 | 74,987 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | A | 6.67 | 15,013 | 100,137 | 15,013 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | A | 6.67 | 258,494 | 1,724,155 | 258,494 | |
Feb 25 2016 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | A | 6.67 | 16,506 | 110,095 | 16,506 | |
Jan 06 2016 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 10.00 | 4,375 | 43,750 | 4,375 | |
Jan 06 2016 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 10.00 | 4,375 | 43,750 | 4,375 | |
Jan 06 2016 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Director | Option Exercise | A | 10.00 | 4,375 | 43,750 | 4,375 | |
Jan 06 2016 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 10.00 | 8,750 | 87,500 | 8,750 | |
Jan 06 2016 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Option Exercise | A | 10.00 | 15,000 | 150,000 | 15,000 | |
Sep 01 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.95 | 1,000 | 6,950 | 1,850 | 850 to 1.9 K (+117.65 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.48 | 200 | 1,295 | 30,000 | 29.8 K to 30 K (+0.67 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.60 | 700 | 4,617 | 29,800 | 29.1 K to 29.8 K (+2.41 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.60 | 4,980 | 32,868 | 29,100 | 24.1 K to 29.1 K (+20.65 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.46 | 420 | 2,713 | 24,120 | 23.7 K to 24.1 K (+1.77 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.59 | 300 | 1,977 | 23,700 | 23.4 K to 23.7 K (+1.28 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.50 | 700 | 4,550 | 23,400 | 22.7 K to 23.4 K (+3.08 %) |
Aug 21 2015 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | P | 6.46 | 100 | 646 | 22,700 | 22.6 K to 22.7 K (+0.44 %) |